State Food and Drug Administration in response to standard Chinese medicine named
Chinese medicine name to be modified will be given to the transition period

Time: 2017-02-28

Source: Beijing Evening News

  Some time ago, Chinese medicine named draft on the network caused a hot debate.   Yesterday morning, the State Food and Drug Administration Director Bi Jingquan in the State Council Information Office held a press conference that the specification of proprietary Chinese medicine name, the focus is to rectify the exaggerated efficacy, suggesting that the curative effect and the term vulgar name, do need to modify the name, also Will give a certain period of time to gradually transition.

  Bi Jingquan said that over the past year, all levels of food and drug regulatory departments focus on remediation of food in the ban on the use of pesticides and food additives, heavy drugs to fight drugs medical equipment fake crime, but food and drug safety problems still Many, to prevent food safety in the field of systemic risk, crack down on drug safety field of counterfeiting fake crime, focus on investigating major cases. The implementation of the quality of food and beverage industry to enhance the project, and vigorously promote the quality of generic drug efficacy evaluation, to encourage new drug research and development.

  Bi Jingquan said that some of the original Chinese medicine has some problems in the expansion of Chinese medicine, such as Xiaogan Ping, after eating can eliminate cancer, "surgeons do not have surgery, scientists do not have to study anti-cancer drugs." Some are named similar problem. In 2014 the State Food and Drug Administration set up a science and technology group, specializing in the ancient Chinese medicine prescription characteristics and laws, the drafting of the technical guidelines for the naming of proprietary Chinese medicines, and now the comments have been completed.

"The State Food and Drug Administration will seriously study the opinions and suggestions put forward." To standardize the naming of proprietary Chinese medicines, the focus is to rectify the exaggerated efficacy, suggesting that the efficacy and terminology of vulgar naming, this is in line with the interests of the people. For the case of naming is not standardized, will be combined with the standard to improve the re-registration and other work gradually standardized, do need to modify the name, will give a certain period of time to gradually transition. "

  Domestic infant milk powder quality has been so that parents are tangled, Bi Jingquan said that the State Food and Drug Administration to encourage infant formula milk powder production enterprises self-built milk source base, can not self-built milk source base to have a stable and regularly reviewed raw materials Supply channels; the implementation of raw materials into the factory batch inspection responsibility, from the source to protect the quality of infant formula milk powder. In the production process of milk powder, enterprises to strict production environment, equipment operation and equipment operation process management, enterprises to the factory's infant formula milk powder products for the whole project batch inspection, the establishment of the whole process of production and management traceability System and product tracking evaluation specification. Infant formula milk powder function claimed to have to be confirmed by scientific experiments, prohibit the express or implied, such as puzzle, enhance immunity and other false propaganda.

 【Disclaimer】
This article is reproduced, only for the exchange, does not mean that the views of this site, the site is not responsible for the authenticity of the content, hereby declare. If you are interested in the contents of the work, copyright and other issues, please contact us in the 30 days, we will be the first time to remove or replace the relevant content, but not related to the commitment to compensation. This article copyright and content interpretation of the original author of all.